diabetes - search results
If you're not happy with the results, please do another search
Dr Elizabeth Robertson, Director of Research at Diabetes UK details the hunt for an alternative to century-old Type 1 diabetes treatment – and looks at how British diabetes research is demanding something better.
With diabetes on the increase in the UK, Dr Louise Gow, Specialist Lead for Eye Health at The Royal National Institute of Blind People (RNIB) explains more about the condition and how it can affect the eyes.
Pete Tate, CEO and Founder of MedTate, explains the role of nutraceuticals in preventing illness when it comes to diabetes in the UK.
A new tool designed to help healthcare professionals boost diabetes referrals to structured education courses is being announced by Diabetes UK and Kent and Medway STP.
New research from Diabetes UK has found that seven out of ten people feel overwhelmed by the demands of living with diabetes, which significantly affects their mental and physical health.
Diabetes UK and JDRF have announced their continued commitment to revolutionising Type 1 diabetes treatment, by awarding £490,000 to fund the next generation of immunotherapy research.
Digitally enabled pathway personalisation is leveraging actionable data insights and dynamic intelligence to drive better outcomes as part of the Prevention 3.0 agenda
New analysis by Diabetes UK has shown that one person is diagnosed with Type 2 diabetes every three minutes in England and Wales.
Peter Robins, from Metabolic Health Solutions (MHS), describes how a new clinical management tool can help individualise treatment of obesity and Type 2 diabetes.
Dr Elizabeth Robertson, Director of Research at Diabetes UK weighs up the costs of Type 2 diabetes remission.
Dr Danny Metoo from University of Salford explains the extent of diabetes care in the world today and the various courses on offer in the field.
The cost of delivering a Type 2 diabetes remission programme in the NHS has been revealed to cost £1000 by a new study.
36% of people with Type 2 diabetes who took part in a weight management programme delivered in NHS primary care are in remission two years later.
New research announced today at the Diabetes UK Professional Conference has revealed shocking health inequalities between people with Type 1 diabetes depending on where they live.
John Grumitt, CEO of Changing Health and Chair of IDEAL Group highlights the importance of tackling the biggest challenges in diabetes care – together.
Jenny Hirst MBE, Co-Chair of the InDependent Diabetes Trust shares her expertise on diabetes from the patients’ perspective.
Professor Graham MacGregor, Chair of Action on Sugar, discusses stopping excessive sugar consumption, whilst investigating obesity and type 2 diabetes.
Adrian Sanders, Secretary-General of The Parliamentarians for Diabetes Global Network (PDGN) reveals how organising globally, acting locally is a sound approach when it comes to tackling diabetes.
Barbara Harpham, Chair of the UK-based Medical Technology Group, explains the role that technology can play in reducing the financial and societal burden of diabetes.
James Cotterell, Director at BBI Healthcare, argues that prescribing products that treat low blood sugar with a precise and measured dose of glucose can improve patient outcomes, reduce patient anxiety and save the NHS money